Antiphospholipid antibodies and covid-19 infection in women with reduced fertility

Česká verzia

Authors: Ulčová-Gallová Z. ^1,2; Cibulka J. ^1,2; Lošan P. ¹
Authors place of work: Genetika Plzeň, s. r. o. ¹; Gynekologicko-porodnická klinika LF UK a FN Plzeň ²
Published in the journal: Ceska Gynekol 2021; 86(3): 210-213
Category:
doi: https://doi.org/10.48095/cccg2021210

Zdroje

1. Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 2005; 5 (12): 917–927. doi: 10.1038/nri1732.

2. Lin L, Lu L, Cao W et al. Hypothesis for potentional pathogenesis of SARS-CoV-2 infection – a review of immune changes in parients with viral pneumonia. Emerg Microbes Infect 2020; 9 (1): 727–732. doi: 10.1080/22221751.2020.1746199.

3. Barreta MH, Gasperin BG, Ferreira R et al. The components of the angiotensin – (1–7) system are differentially expressed during follicular wave in catle. J Renin Angiotensin Aldosterone Syst 2015; 16 (2): 275–283. doi: 10.1177/ 1470320313491996.

4. Jiao J. Under the epidemic situation of covid-19, should special attention to pregnant women be given? J Med Virol 2020; 92 (9): 1371–1372. doi: 10.1002/jmv.25771.

5. Qin C, Zhou L, Hu Z et al. Dysregulation of immune response in patients with corona virus 2019 (Covid-19) in Wuhan, China. Clin Infect Dis 2020; 71 (15): 762–768. doi: 10.1093/cid/ciaa248.

6. Xu H, Deng L, Penq J et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020; 12 (1): 8. 10.1038/s41368-020-0074-x.

7. Kwak-Kim J, Ota K, Sung N et al. Covid-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol 2020; 141: 103168. doi: 10.1016/j.jri.2020.103168.

8. Kutteh WH, El-Taha L, Ghazeeri G. Impact of Covid-19 infection on induction of IgA Antiphospholipid antibodies: thrombo-inflammatory risks to pregnant women. J Obstet Gynecol 2020; 1 (1): 1–3.

9. Zhang Y, Xiao M, Zhang S et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020; 382 (17): e38. doi: 10.1056/NEJMc2007575.

10. Kutteh WH, Hinote CD. Antiphospholipid antibody syndrome. Obstet Gynecol Clin North Am 2014; 41 (1): 113–132. doi: 10.1016/j.ogc.2013.10.004.

11. Cardoso EM, Hundal J, Feterman D et al. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol 2020; 39 (9): 2811– –2815. doi: 10.1007/s10067-020-05310-1.

12. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 196: thromboembolism in pregnancy. Obstet Gynecol 2018; 132 (1): e1–e17. doi: 10.1097/AOG.000 0000000002706.

13. Davenport WB, Kutteh WH. Inherited thrombophilias and adverse pregnancy outcome: a review of screening patterns and recommendations. Obstet Gynecol Clin North Am 2014; 41 (4): 133–144. doi: 10.1016/j.ogc.2013.10. 005.

14. D’Souza RD, Malhamé I, Teshler L et al. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxix in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020; 99 (9): 1110–1120. doi: 10.1111/aogs.13962.

15. Yuki K, Fujiogi M, Koutsogiannaki S. COVID--19 pathophysiology: a review. Clin Immunol 2020; 215: 108427. doi: 10.1016/j.clim.2020. 108427.

16. Li M, Chen L, Zhang J et al. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PloS One 2020; 15 (4): e0230295. doi: 10.1371/journal.pone.0230295.

17. Dashraath P, Wong JL, Lim MX. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020; 222 (6): 521–531. doi: 10.1016/j.ajog.2020.03.021.

18. Kwak-Kim JY, Kwak FM, Ainbinder SW et al. Elevated peripheral blood nature killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35 (4): 363–369. doi: 10.1111/j.1600-0897.1996.tb00495.x.

19. Quenby S, Kalumbi C, Bates M et al. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriages. Fertil Steril 2005; 84 (4): 980–984. doi: 10.1016/j.fertnstert.2005.05.012.

20. Ulčová-Gallová Z, Pešek M, Haschová M et al. Výsledky léčby u vybraných infertilních pacientek s vysokou densitou endometriálních NK buněk CD56+ a CD16+. Druhá část. Ceska Gynekol 2018; 83 (2): 115–118.

21. Lédée BN, Prat-Ellenberg L, Petitbarat M et al. Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious? J Reprod Immunol 2018; 127: 11–15. doi: 10.1016/j.jri.2018.03.003.

22. Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is bloked by a clinically proven protease inhibitor. Cell 2020; 181 (2): 271–280. doi: 10.1016/j.cell.2020.02.052.

23. Cavalcante MB, Sarno M, Niag M et al. Lymphocyte immunotherapy for recurrent miscarriages: predictors of therapeutic success. Am J Reprod Immunol 2018; 79 (6): e12833. doi: 10.1111/aji.12833.

24. Coulam CB, Acacio B. Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol 2012; 67 (4): 296–304. doi: 10.1111/j.1600-0897.2012.01111.x.

25. Caccialanza R, Laviano A, Lobascio F et al. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (covid-19): rationale and feasibility of a shared pragmatic protocol. Nutrition 2020; 74: 110835. doi: 10.1016/j.nut.2020. 110835.